These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

605 related items for PubMed ID: 14578014

  • 1. Intravenous flumazenil versus oxazepam tapering in the treatment of benzodiazepine withdrawal: a randomized, placebo-controlled study.
    Gerra G, Zaimovic A, Giusti F, Moi G, Brewer C.
    Addict Biol; 2002 Oct; 7(4):385-95. PubMed ID: 14578014
    [Abstract] [Full Text] [Related]

  • 2. Intravenous flumazenil following prolonged exposure to lormetazepam in humans: lack of precipitated withdrawal.
    Gerra G, Giucasto G, Zaimovic A, Fertonani G, Chittolini B, Avanzini P, Caccavari R, Delsignore R.
    Int Clin Psychopharmacol; 1996 Jun; 11(2):81-8. PubMed ID: 8803645
    [Abstract] [Full Text] [Related]

  • 3. [Comparison of 6 different methods for lorazepam withdrawal. A controlled study, hydroxyzine versus placebo].
    Lemoine P, Touchon J, Billardon M.
    Encephale; 1997 Jun; 23(4):290-9. PubMed ID: 9417395
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Benzodiazepine tapering: a prospective study.
    Vikander B, Koechling UM, Borg S, Tönne U, Hiltunen AJ.
    Nord J Psychiatry; 2010 Aug; 64(4):273-82. PubMed ID: 20629611
    [Abstract] [Full Text] [Related]

  • 6. Divalproex sodium in alcohol withdrawal: a randomized double-blind placebo-controlled clinical trial.
    Reoux JP, Saxon AJ, Malte CA, Baer JS, Sloan KL.
    Alcohol Clin Exp Res; 2001 Sep; 25(9):1324-9. PubMed ID: 11584152
    [Abstract] [Full Text] [Related]

  • 7. Reduction of aggression during benzodiazepine withdrawal: effects of flumazenil.
    Saxon L, Borg S, Hiltunen AJ.
    Pharmacol Biochem Behav; 2010 Aug; 96(2):148-51. PubMed ID: 20451546
    [Abstract] [Full Text] [Related]

  • 8. Anticonvulsant efficacy of the low-affinity partial benzodiazepine receptor agonist ELB 138 in a dog seizure model and in epileptic dogs with spontaneously recurrent seizures.
    Löscher W, Potschka H, Rieck S, Tipold A, Rundfeldt C.
    Epilepsia; 2004 Oct; 45(10):1228-39. PubMed ID: 15461677
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Dependence on benzodiazepines. Clinical and biological aspects].
    Pelissolo A, Bisserbe JC.
    Encephale; 1994 Oct; 20(2):147-57. PubMed ID: 7914165
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. High dose benzodiazepine dependence: description of 29 patients treated with flumazenil infusion and stabilised with clonazepam.
    Quaglio G, Pattaro C, Gerra G, Mathewson S, Verbanck P, Des Jarlais DC, Lugoboni F.
    Psychiatry Res; 2012 Aug 15; 198(3):457-62. PubMed ID: 22424905
    [Abstract] [Full Text] [Related]

  • 13. Treatment of benzodiazepine overdose with flumazenil. The Flumazenil in Benzodiazepine Intoxication Multicenter Study Group.
    Clin Ther; 1992 Aug 15; 14(6):978-95. PubMed ID: 1286503
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Flumazenil in alcohol withdrawal.
    Nutt D, Glue P, Wilson S, Groves S, Coupland N, Bailey J.
    Alcohol Alcohol Suppl; 1993 Aug 15; 2():337-41. PubMed ID: 7748321
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The role of flumazenil in the treatment of benzodiazepine dependence: physiological and psychological profiles.
    Hood S, O'Neil G, Hulse G.
    J Psychopharmacol; 2009 Jun 15; 23(4):401-9. PubMed ID: 19164495
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The effect of mianserin add-on, on the intensity of opioid withdrawal symptoms during detoxification program--a randomized, double blind, placebo controlled, prospective study.
    Herman I, Shamir D, Bar-Hamburger R, Pick CG, Schreiber S.
    Addict Behav; 2005 Jul 15; 30(6):1154-67. PubMed ID: 15925125
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.